Status:
RECRUITING
Promoting Independence With Compensatory Cognitive Rehabilitation
Lead Sponsor:
University of Delaware
Conditions:
Mild Cognitive Impairment
Alzheimer Disease
Eligibility:
All Genders
60-90 years
Phase:
NA
Brief Summary
Alzheimer's disease (AD) is one of the leading causes of disability in older adults. Because pharmacological approaches do not seem to prevent or slow the disease, clinicians need non-pharmacological ...
Detailed Description
Clinical Trial Study Design: Pilot Individually Randomized Group-Treatment Trial Study Site: University of Delaware. All research activities will occur via telehealth. Study Participants: Approximat...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 60-90 years of age
- English Speaking
- Functional Vision and Hearing to Complete Phone Screen
- not taking or stable ( \>2 months) on nootropic meds
- amnestic mild cognitive impairment from probable Alzheimer's disease
- Exclusion Criteria
- History of major psychiatric disorder (e.g. schizophrenia)
- Untreated major depression
- History of medical diseases that are related to cognitive impairment
- current participation in another clinical trial related to memory
- major auditory, visual, or motor impairment that would affect their ability to participate in the study
- substance use disorder in the past 5 years
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04820335
Start Date
February 1 2022
End Date
December 31 2025
Last Update
November 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Delaware
Newark, Delaware, United States, 19716